Abstract

Background: Considering the extraordinary situation of COVID-19, Türkiye government alongside with civil organizations used this opportunity to inform people about harmful effects of smoking during pandemic period and to encourage them for cessation. Accordingly, the primary aim of this paper is to compare cigarette sales data pre- and post- COVID-19 pandemic in Türkiye.

Methods: The cigarette sales in January – June 2020 were compared with the same months in 2019. Permutation Wilcoxon Signed-Rank Test was used for data analysis. A 6-month prediction was made for the remaining months in 2020 using the Box Jenkins ARIMA (Auto Regressive Integrated Moving Average) time series model. The monthly cigarette sales were graphed against the expected monthly cigarette sales (average cigarette sales in 2019) to determine pattern pre- and post-COVID-19.

Results: There was a significant decrease in manufactured cigarette sales in January – June 2020 comparing with the same months in 2019. The cigarette sales in February – May 2020 were below the expected monthly cigarette sales. If this trend continues, cigarette sales will drop to 10,002,121,177 sticks/month by the end of 2020.

Conclusions: Governments and organizations should use this pandemic period to strengthen the implementation of existing tobacco control policies and increase smoking cessation campaigns.

Keywords: COVID-19, smoking, pandemics, tobacco control

Introduction

Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was initially identified in December 2019 in Wuhan, China then quickly spread across the world. This outbreak was declared as a public health emergency of international concern on January 30, 2020 by the World Health Organization (WHO).1

In order to prepare for and effectively respond to this pandemic, the Ministry of Health (MoH) of Türkiye formed a COVID-19 Scientific Advisory Board (CSAB) on January 10, 2020, two-months prior to the identification of the first COVID-19 case. Guidelines for health professionals as well as all additional relevant materials were published and made available on MoH’s website.2 Once the first confirmed case of COVID-19 disease was identified on March 11, 2020,3 the government also took steps to close non-essential businesses including cafes, bars, restaurants and night clubs, prohibit mass gatherings and limit movement, as well as, use of public places.2 As of June 1, 2020, the total number of COVID-19 cases reported in Türkiye was 164,769, the total number of deaths reported was 4,563 and the overall case fatality rate was 2.8 % with 128,947 patients cured.4

Tobacco smoking is recognized as a key risk factor for many respiratory infections and increases the severity of respiratory diseases. While evidence on whether current tobacco smokers are at increased risk of disease, morbidity and mortality from COVID-19 are limited, recent studies have shown a likely association between smoking and COVID-19. A study that aimed to investigate the factors affecting the progression of pneumonia in COVID-19 patients in three tertiary hospitals in Wuhan suggested that smoking is associated with disease progression.5 A systematic review of five studies on COVID-19 that included information on patients’ smoking status indicated that smokers compared to no-smokers were 1.4 times more likely (RR=1.4, 95% CI: 0.98–2.00) to endure severe symptoms of COVID-19, and about 2.4 times more likely to be admitted to an intensive care unit (ICU), require mechanical ventilation or die (RR=2.4, 95% CI: 1.43–4.04).6 Another study assessing the clinical characteristics of COVID-19 in a select cohort of patients throughout China showed that a higher percentage of current and former smokers were considered severe cases as compared to nonsmokers.7 Smoking has also been found to be associated with increased development of acute respiratory distress syndrome which is one of the key complications for severe COVID-19 cases.8,9

Furthermore, smokers are likely more at risk of contracting COVID-19 as smoking requires the contact between possibly contaminated fingers and/or cigarettes with the mouth, thereby increasing the possibility of the transmission of COVID-19.10 Smoking is also one of the main risk factors for non-communicable diseases such as cardiovascular diseases and cancer which makes COVID-19 patients more vulnerable for severe disease.11 Studies from other outbreaks caused by viruses from the same family as COVID-19, such as Middle East respiratory syndrome (MERS) for example, also suggest the likely association between tobacco smoking and increased risk of infection, poor prognosis and/or mortality for infectious respiratory diseases.12,13

In Türkiye, tobacco use is a pressing public health concern. According to available data from the 2016 Global Adult Tobacco Survey (GATS), 31.6% (19.2 million) of the population were current tobacco smokers (44.1% of men, 19.2% of women). Those who smoked tobacco on a daily basis were found to smoke an average of 18.0 cigarettes per day (18.9 among men and 15.8 among women). About a third (32.8%) of current tobacco smokers planned to or were thinking about quitting smoking and about a quarter (24.6%) made a quit attempt in the past year. Knowledge about the harms of tobacco use was high; almost 90% of Turkish adults believed that smoking causes serious illnesses such as lung cancer (96.3%), heart attack (95.6%), chronic lung diseases (92.1%), stroke (86.9%), and stomach cancer (86.4%). Likewise, awareness about the harms of second-hand smoke was also high; 83.3% and 95.4% of all Turkish adults believed that breathing second-hand smoke causes serious illness among non-smokers and causes lung illness in children, respectively.14

Together with MoH, the Turkish Green Crescent Society - a non-profit non-governmental organization (NGO) in Türkiye fighting against addiction including cigarette smoking - delivered strong messages via mainstream and social media about the harmful effects of smoking during COVID-19. According to Green Crescent, smoking cessation calls to the NGO increased from 12 percent of total calls before the COVID-19 pandemic to 82 percent of total calls during the COVID-19 pandemic.15 However, currently there are no available data about the effect of the COVID-19 pandemic on cigarette sales in Türkiye to help us better understand if people may have quit smoking during this global crisis. Accordingly, the primary aim of this paper is to compare cigarette sales data pre- and post- COVID-19 pandemic in Türkiye.

Material and Methods

Monthly manufactured cigarette sales data from January 2019 through June 2020 were obtained from the Turkish Tobacco and Alcohol Market Regulatory Authority (TAPDK), the government organization charged with regulating tobacco use. As the first case of COVID-19 disease was identified in December 2019 in Wuhan, China, and WHO declared the disease as a Public Health Emergency of International Concern on January 30, 2020, cigarette sales in January, February, March, April, May, and June 2020 were compared with the same months in 2019. Permutation Wilcoxon Signed-Rank Test was used to analyze the data. The relative change of manufactured cigarette sales from 2019 to 2020 was analyzed.

The average monthly cigarette sales in 2019 (expected monthly cigarette sale) was calculated. Subsequently, the monthly cigarette sales were graphed against the average monthly cigarette sales in 2019 to determine pattern pre- and post-COVID-19.

With Box Jenkins ARIMA (Auto Regressive Integrated Moving Average) time series model, a six month prediction was made for the remaining months in 2020 (July to December).

For the forecast of the remaining months in 2020, we created two forecast models, an estimate made only with 2019 months and a forecast containing the 2020 COVID-19 months.

In order to decide the most suitable model; first, a unit root test was used to determine the number of differences required for time series. Then, the variance of the data was stabilized by box cox transformations. This removed the serial trend and seasonality, the movements of the data were randomized, and the serial was stabilized.

ACF (Autocorrelation Function) and PACF (Partial Autocorrelation Function) graphs of the stationary series were plotted to identify the AR (Auto Regressive) and MA (Moving Average) coefficients and 5 different models were created. AICC (Akaike Information Criterion with Correction) values were calculated to decide the most appropriate of these models. The model with the lowest AICC value was evaluated and showed that there was no remaining autocorrelation from the residuals and that they cannot be separated from a series of white noise with a Ljung-Box test.

The resulting specifications for the two models were ARIMA (1,1,1)12 for Model 1 (based on 2019 and available 2020 data, Ljung-Box test Q=1.7317, p-value = 0.6299), and ARIMA (1,1,0)12 for Model 2 (based on only 2019 data, Ljung-Box test Q=4.9015, p-value = 0.1792).

Cigarette sales tend to decrease during Ramadan. Therefore, a correction was made in the months of Ramadan for both years (May 6 to June 3 in 2019 and April 23 to May 23 in 2020). The correction adjusted for the average decrease in cigarette sales during Ramadan using monthly sales from 2005 to 2010.16 Based on the above correction, cigarette sales in those Ramadan months were relatively increased.

The type one error rate was accepted as 0.05. Statistical analysis was conducted with R Studio Version 1.2.5042. Figures and tables were made with Microsoft Excel. Ethical approval is not required for this study.

Results

Monthly cigarette sales from January to June in 2019 and 2020 are presented in Table 1. There was a 21.4% increase in the number of manufactured cigarettes sold in January, and 20.3% increase in June 2020 (when lockdowns lifted on June 1st) when compared to same months in 2019. The number of manufactured cigarettes sold in February, March, April, and May 2020, on the other hand, decreased when compared to the number of manufactured cigarettes sold during the same months in 2019. The biggest difference was observed in April where there was a 40.1% decrease in monthly cigarette sales between 2019 and 2020 (Table 1). A statistically significant decrease (6.8%) was noticed in the cigarette sales during first six months of 2020 comparing to the same months in 2019 (Z = 2.8031, p-value = 0.005062); the significance level was tested using the Wilcoxon Signed-Rank Test.

a. Forecasted using 2019 and 2020 covid months b. Relative change calculated by ((2020-2019) / 2019)*100 c.Corrected for Ramadan
Table 1. Observed and forecasted cigarettes sales by month in 2020
Month
2019
2020
Relative Change (%)b
January 
9,247,940,030
11,225,553,750
21.38%
February 
9,260,562,760
8,090,884,800
-12.63%
March 
10,974,929,440
9,715,313,860
-11.48%
April 
12,309,450,904
7,616,697,074c
-38.12%
May 
10,513,904,244c
9,432,645,636c
-10.28%
June 
10,344,251,180c
12,449,577,820
20.35%
July 
12,601,865,060
10,699,882,035 a
-15.09%
August 
10,330,792,840
10,200,373,057 a
-1.26%
September 
8,852,760,460
10,057,771,572 a
13.61%
October 
9,082,758,020
10,017,061,225 a
10.29%
November 
8,225,688,600
10,005,439,100 a
21.64%
December 
9,061,153,100
10,002,121,177 a
10.38%

As seen in Figure 1, the cigarette sales in January and June of 2020 were above the average monthly cigarette sales (10,067,171,387 sticks/month) while the cigarette sales in February, March, April, and May of 2020 located below the average line for monthly cigarette sales in 2019.

Figure 1. Monthly cigarette sales compared to average monthly cigarette sales

Table 1 and Figure 2 show the observed and forecasted cigarette sales. Cigarette sales are forecasted to decrease from 11,225,553,750 in January 2020 to 10,002,121,177 in December 2020 based on all available 2019 and 2020 data.

Figure 2. Observed and forecasted cigarette sales, 2019-2020

Discussion

This study compared cigarette sales data pre- and post- COVID-19 pandemic in Türkiye. Findings showed that while there was an initial increase in January 2020, cigarette sales decreased significantly during the subsequent months (February, March, April, and May of 2020) when compared to the same months of the previous year. Though there was a sudden increase in cigarette sales in June 2020 compared to June 2019, the forecasts reveal that cigarette sales will continue to drop in Türkiye for July and August of 2020 but will then increase for the remaining months of 2020 relative to 2019 sales.

The initial spike in January could potentially be due to stockpiling where smokers accumulate a large quantity of cigarettes as a result of the uncertainty surrounding COVID-19. Data from Altria Group Inc. showed an initial increase of 14% in sales.17 Likewise, Nielsen data also revealed a 1.1% increase in sales in the United States towards the end of March when states started enacting stay-at-home orders and a 9% increase in the United Kingdom (UK) at around the same time.18,19

The subsequent drop in cigarette sales during COVID-19 lockdown suggest that some Turks may have reduced and quit smoking as a result of the pandemic. This finding is consistent with the increased number of cessation calls received by the Green Crescent,15 as well as, with trends in several other countries; a survey showed that over 300,000 smokers in the UK may have quit smoking, 550,000 have attempted to quit and 2.4 million have decreased consumption during the COVID-19 crisis.20 Klemperer et al (2020) also found that in the United States motivation to quit tobacco and electronic cigarette use during the pandemic increased by 35.6% for tobacco users and 37.6% for electronic cigarette users. Moreover, about 22.9% and 22.1% of tobacco and electronic cigarette users respectively reported an attempt to quit.21 Likewise, in Italy, about 3% of smokers also decided to quit smoking during the COVID-19 lockdown.22 Interestingly, while it appeared that for other countries cigarette sales decreased after stay-at-home related orders were passed, sales started to drop in Türkiye prior to the identification of the first case. This might be as a result of the strong messages against smoking that were given by public health organizations, associations and academicians after the first studies about the likely association between smoking and COVID-19 were published.

The number of daily COVID-19 cases dropped to under the 1000 cases per day for the first time on the 20th of May,23 and the government announced the beginning of normalization process. By the first of June some of the prior limitations were removed by the government and restaurants, cafes, patisseries, tea gardens, association tavern, swimming pool, and spa started to open until 22:00, within the specified rules. This could help explain the increase in cigarette sales in June. Additionally, civil servants who were on administrative leave or included in the flexible working system started their regular work.24 This all may also be a possible reason for the sudden increase of cigarette sales in June 2020.

Some may think that the decrease in manufactured cigarette sales may be influenced by the lockdown rather than concerns about COVID-19, but our results show that the decrease in sales happened before the confirmation of first COVID-19 case and the beginning of lockdown in Türkiye. Despite a slightly increase in June the cigarette sales remained decreased after the lockdown too. A new poll in Finland, conducted by the anti-smoking organization Suomen ASH, found that 15% of people who stopped smoking in the last year did so because of coronavirus. In this poll of more than 2,000 people, health in general was considered by 84% to be the most common reason to want to give up cigarettes. That’s up from 73% when the polling was last carried out in 2018.25

Our forecast revealed that cigarette sales drop again in July and August but then increase for the remainder of 2020 relative to 2019 sales. Given this, it will be vital for public health advocates to continue to strengthen the implementation of tobacco control policies and carry out smoking cessation campaigns to alter this trajectory.

There are some limitations with the study; factors other than the COVID-19 pandemic could have also influenced cigarettes sales in Türkiye. It is also difficult to disentangle COVID-19 related byproducts like reduced income, reduced access to stores and public spaces, and increased awareness of potential risk factors to COVID-19 related illness. Future studies could be undertaken to fill this gap. Qualitative studies are also needed to better understand what helps motivate smokers in Türkiye and around the world to quit during such pandemics. Moreover, given that this study only examined data from 2019 and 2020, the question of how this crisis will change tobacco use in the long-term also need to be further explored. While this study primarily focused on the impact of the COVID-19 pandemic on cigarette sales during the first half of 2020, it is important to acknowledge that external factors such as cigarette pricing and tax increases may also have influenced sales trends. Future research could further explore these socio-economic variables to provide a more comprehensive understanding of their effects on cigarette consumption during this unprecedented period.

Conclusions

Türkiye has made significant progress in tackling its tobacco epidemic. To date, it is one of the only countries in the world to have fulfilled all of WHO’s MPOWER measures. This study revealed that during the COVID-19 pandemic, cigarette sales significantly decreased in the country and are forecasted to drop further before it increases again for the remaining months of 2020. This trend suggests that Turks might be reducing and quitting smoking. However, to maintain this positive trajectory, public health advocates in the country should continue to utilize COVID-19 as a unique opportunity to strengthen the implementation of existing tobacco control policies and increase smoking cessation campaigns to further foster an environment that will encourage smokers to quit and protect public health.

Ethical approval

No ethical committee approval was required.

Author contribution

Study conception and design: MAE, TE, CE, CH; data collection: TE, AP, AAA; analysis and interpretation of results: EŞY, KW, AAA, TE; draft manuscript preparation: TE, AP, AAA, CH. The author(s) reviewed the results and approved the final version of the article.

Source of funding

The authors declare the study received no funding.

Conflict of interest

The authors declare that there is no conflict of interest.

References

  1. World Health Organization (WHO). Coronavirus disease (COVID-19) pandemic [Internet]. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 (Accessed on May 26, 2020).
  2. World Health Organization (WHO). COVID-19 health system response monitor - Turkey [Internet]. Available at: https://www.covid19healthsystem.org/countries/turkey/countrypage.aspx (Accessed on June 12, 2020).
  3. T.C. Sağlık Bakanlığı. COVID-19 - Yeni koronavirüs hastalığı [Internet]. Available at: https://covid19bilgi.saglik.gov.tr/ (Accessed on May 26, 2020).
  4. T.C. Sağlık Bakanlığı. Turkiye'deki güncel durum [Internet]. Available at: https://covid19.saglik.gov.tr/ (Accessed on June 12, 2020).
  5. Liu W, Tao ZW, Wang L, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J (Engl) 2020; 133: 1032-1038. https://doi.org/10.1097/CM9.0000000000000775
  6. Vardavas CI, Nikitara K. COVID-19 and smoking: a systematic review of the evidence. Tob Induc Dis 2020; 18: 1-4. https://doi.org/10.18332/tid/119324
  7. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382: 1708-1720. https://doi.org/10.1056/NEJMoa2002032
  8. Hsieh SJ, Zhuo H, Benowitz NL, et al. Prevalence and impact of active and passive cigarette smoking in acute respiratory distress syndrome. Crit Care Med 2014; 42: 2058-2068. https://doi.org/10.1097/CCM.0000000000000418
  9. Calfee CS, Matthay MA, Kangelaris KN, et al. Cigarette smoke exposure and the acute respiratory distress syndrome. Crit Care Med 2015; 43: 1790-1797. https://doi.org/10.1097/CCM.0000000000001089
  10. World Health Organization (WHO). Coronavirus disease (COVID-19): Tobacco [Internet]. Available at: https://www.who.int/news-room/q-a-detail/q-a-on-tobacco-and-covid-19 (Accessed on June 12, 2020).
  11. World Health Organization (WHO). Noncommunicable diseases [Internet]. Available at: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases (Accessed on June 12, 2020).
  12. Seys LJM, Widagdo W, Verhamme FM, et al. DPP4, the Middle East respiratory syndrome coronavirus receptor, is upregulated in lungs of smokers and chronic obstructive pulmonary disease patients. Clin Infect Dis 2018; 66: 45-53. https://doi.org/10.1093/cid/cix741
  13. Alraddadi BM, Watson JT, Almarashi A, et al. Risk factors for primary Middle East respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014. Emerg Infect Dis 2016; 22: 49-55. https://doi.org/10.3201/eid2201.151340
  14. Centers for Disease Control and Prevention (CDC). Global adult tobacco survey, fact sheet, Turkey 2016 [Internet]. 2016. Available at: https://nccd.cdc.gov/GTSSDataSurveyResources/Ancillary/DownloadAttachment.aspx?ID=3452
  15. AA. Koronavirüs sürecinde sigarayı bırakmak isteyenlerin sayısı arttı [Internet]. Available at: https://www.aa.com.tr/tr/saglik/koronavirus-surecinde-sigarayi-birakmak-isteyenlerin-sayisi-artti/1833703 (Accessed on May 26, 2020).
  16. Warren CW, Erguder T, Lee J, et al. Effect of policy changes on cigarette sales: the case of Turkey. Eur J Public Health 2012; 22: 712-716. https://doi.org/10.1093/eurpub/ckr157
  17. Bloomberg. Marlboros haven't bounced back after coronavirus stockpiling [Internet]. Available at: https://www.bloomberg.com/news/articles/2020-05-12/marlboros-haven-t-bounced-back-after-coronavirus-stockpiling (Accessed on June 15, 2020).
  18. Tobaccoreporter. Following consumer stockpiling, US cigarette sales plunge [Internet]. Available at: https://tobaccoreporter.com/2020/04/17/following-consumer-stockpiling-u-s-cigarette-sales-plunge/ (Accessed on June 15, 2020).
  19. Financial Times. Smokers stock up on tobacco and nicotine products [Internet]. Available at: https://www.ft.com/content/362d7d51-6561-493b-a29b-72784157cca7 (Accessed on June 15, 2020).
  20. The Guardian. More than 300,000 UK smokers may have quit owing to Covid-19 fears [Internet]. Available at: https://www.theguardian.com/society/2020/may/04/more-than-300000-uk-smokers-may-have-quit-owing-to-covid-19-fears (Accessed on May 26, 2020).
  21. Klemperer EM, West JC, Peasley-Miklus C, Villanti AC. Change in tobacco and electronic cigarette use and motivation to quit in response to COVID-19. Nicotine Tob Res 2020; 22: 1662-1663. https://doi.org/10.1093/ntr/ntaa072
  22. Di Renzo L, Gualtieri P, Pivari F, et al. Eating habits and lifestyle changes during COVID-19 lockdown: an Italian survey. J Transl Med 2020; 18: 229. https://doi.org/10.1186/s12967-020-02399-5
  23. T.C. Sağlık Bakanlığı. COVID-19 situation report Turkey | Haftalık Rapor / Weekly Report [Internet]. 2020. Available at: https://sbsgm.saglik.gov.tr/TR,66560/haftalik-rapor--weekly-report.html (Accessed on Aug 14, 2020).
  24. CNNTÜRK. Son dakika... Cumhurbaşkanı Erdoğan açıkladı! 1 Haziran'dan itibaren hizmet vermeye başlayacak [Internet]. 2020. Available at: https://www.cnnturk.com/turkiye/son-dakika-cumhurbaskani-erdogan-yeni-koronavirus-tedbirlerini-acikliyor (Accessed on Aug 14, 2020).
  25. News Now Staff. Thousands of Finns quit smoking during coronvirus pandemic | News Now Finland [Internet]. 2020. Available at: https://newsnowfinland.fi/health-lifestyle/thousands-of-finns-quit-smoking-during-coronvirus-pandemic (Accessed on Oct 16,2020).

How to cite

Ahmadi, A. A., Erdöl, M. A., Pakdemirli, A., Şafak Yılmaz, E., Hoe, C., Welding, K., Ergüder, T., & Erdöl, C. (2025). Effect of COVID-19 pandemic on cigarette sales: The case of Türkiye. Turkish Journal of Tobacco Control, 5(1), 1-9. https://tjtc.org/article/view/1